High Risk HRpos HER2neg EBC
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Released: July 25, 2024

Expiration: July 24, 2025

Activity

Progress
1
Course Completed